The incidence rate of Rifampin-resisitant Staphylococci after short term administration of rifaximin in cirrhotic patients
Not Applicable
Recruiting
- Conditions
- Codes for special purposes
- Registration Number
- KCT0001753
- Lead Sponsor
- Ewha Womans University Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 180
Inclusion Criteria
Liver cirrhosis patient who taken rifaximin more than 7 days to prevent hepatic encephalopathy or to manage enterocolitis
Exclusion Criteria
1) who died or was follow up loss
2) who treated with rifampin
3) who administered rifaximin already
4) who judged that cannot be enrolled by researcher
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Prevalence of rifampin resistant staphylococcus
- Secondary Outcome Measures
Name Time Method Rifampin-resistant Staphylococci carrier rate before administer rifaximin